[HTML][HTML] Dopamine receptor subtypes, physiology and pharmacology: new ligands and concepts in schizophrenia
JC Martel, S Gatti McArthur - Frontiers in pharmacology, 2020 - frontiersin.org
Dopamine receptors are widely distributed within the brain where they play critical
modulator roles on motor functions, motivation and drive, as well as cognition. The …
modulator roles on motor functions, motivation and drive, as well as cognition. The …
[HTML][HTML] Dopamine and dopamine receptors in Alzheimer's disease: a systematic review and network meta-analysis
X Pan, AC Kaminga, SW Wen, X Wu… - Frontiers in aging …, 2019 - frontiersin.org
Background: The dopaminergic system has been associated with the progression of
Alzheimer's disease. But previous studies found inconsistent results regarding the …
Alzheimer's disease. But previous studies found inconsistent results regarding the …
[HTML][HTML] The endocannabinoid system as a target in cancer diseases: are we there yet?
The endocannabinoid system (ECS) has been placed in the anti-cancer spotlight in the last
decade. The immense data load published on its dual role in both tumorigenesis and …
decade. The immense data load published on its dual role in both tumorigenesis and …
[HTML][HTML] Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?
P Yang, JS Perlmutter, TLS Benzinger, JC Morris… - Ageing research …, 2020 - Elsevier
Parkinson disease (PD) is a neurodegenerative disorder characterized by motor and non-
motor symptoms which relentlessly and progressively lead to substantial disability and …
motor symptoms which relentlessly and progressively lead to substantial disability and …
[HTML][HTML] Neuronal dopamine D3 receptors: translational implications for preclinical research and CNS disorders
B Kiss, I Laszlovszky, B Krámos, A Visegrády, A Bobok… - Biomolecules, 2021 - mdpi.com
Dopamine (DA), as one of the major neurotransmitters in the central nervous system (CNS)
and periphery, exerts its actions through five types of receptors which belong to two major …
and periphery, exerts its actions through five types of receptors which belong to two major …
Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders
R Juza, K Musilek, E Mezeiova… - Medicinal Research …, 2023 - Wiley Online Library
Dopamine is a biologically active amine synthesized in the central and peripheral nervous
system. This biogenic monoamine acts by activating five types of dopamine receptors (D1 …
system. This biogenic monoamine acts by activating five types of dopamine receptors (D1 …
[HTML][HTML] The pathophysiology and the therapeutic potential of cannabinoids in prostate cancer
Simple Summary Prostate cancer, after lung cancer, is the leading cause of death among
men. The incidence rate of prostate cancer varies worldwide between regions and …
men. The incidence rate of prostate cancer varies worldwide between regions and …
Heterobivalent Ligand for the Adenosine A2A–Dopamine D2 Receptor Heteromer
D Pulido, V Casado-Anguera… - Journal of medicinal …, 2022 - ACS Publications
AG protein-coupled receptor heteromer that fulfills the established criteria for its existence in
vivo is the complex between adenosine A2A (A2AR) and dopamine D2 (D2R) receptors …
vivo is the complex between adenosine A2A (A2AR) and dopamine D2 (D2R) receptors …
Synthesis and biological evaluation of fused tricyclic heterocycle piperazine (piperidine) derivatives as potential multireceptor atypical antipsychotics
X Cao, Y Zhang, Y Chen, Y Qiu, M Yu… - Journal of medicinal …, 2018 - ACS Publications
Herein, a novel series of multireceptor ligands was developed as polypharmacological
antipsychotic agents using the designed multiple ligand approach between dopamine …
antipsychotic agents using the designed multiple ligand approach between dopamine …
Rationalizing a prospective coupling effect of cannabinoids with the current pharmacotherapy for melanoma treatment
Melanoma is one of the leading fatal forms of cancer, yet from a treatment perspective, we
have minimal control over its reoccurrence and resistance to current pharmacotherapies …
have minimal control over its reoccurrence and resistance to current pharmacotherapies …